Krsnaa Diagnostics Limited (BOM:543328)
India · Delayed Price · Currency is INR 563.75
+13.95 (2.54%)
At close: Aug 21, 2026
Krsnaa Diagnostics Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 8,413 | 7,987 | 7,172 | 6,196 | 4,871 | 4,555 |
Revenue Growth | 13.70% | 11.37% | 15.74% | 27.20% | 6.95% | 14.88% |
Gross Profit Gross Profit Growth | 6,595 | 6,197 | 5,445 | 4,683 | 3,972 | 3,799 |
Operating Income Operating Income Growth | 1,476 | 1,474 | 1,018 | 696.44 | 692.39 | 903.37 |
Net Income Net Income Growth | 974.62 | 1,014 | 776.08 | 568.37 | 621.11 | 683.88 |
Earnings Per Share EPS Growth | 29.67 | 30.88 | 23.56 | 17.31 | 19.29 | 22.88 |
EPS Growth | 21.86% | 31.07% | 36.11% | -10.26% | -15.69% | 86.72% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 3,607 | 3,607 | 684.36 | 1,752 | 1,088 | 2,419 |
Total Debt Total Debt Growth | 5,343 | 5,343 | 2,035 | 1,598 | 324.81 | 409.92 |
Net Cash (Debt) Net Cash Growth | -1,736 | -1,736 | -1,351 | 153.97 | 763.15 | 2,009 |
Net Cash Growth | - | - | - | -79.82% | -62.01% | - |
Net Cash Per Share Net Cash Per Share Growth | -52.85 | -52.85 | -41.00 | 4.69 | 23.70 | 67.22 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 1,431 | 873.27 | 243.45 | 763.01 | 1,284 |
Capital Expenditures CapEx Growth | - | -2,193 | -1,266 | -1,939 | -1,414 | -1,322 |
Free Cash Flow Free Cash Flow Growth | - | -761.61 | -393 | -1,695 | -650.59 | -37.95 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 78.39% | 77.58% | 75.92% | 75.58% | 81.53% | 83.41% |
Operating Margin | 17.55% | 18.45% | 14.19% | 11.24% | 14.21% | 19.84% |
Pretax Margin | 14.90% | 16.32% | 14.32% | 11.30% | 16.46% | 18.99% |
Profit Margin | 11.58% | 12.70% | 10.82% | 9.17% | 12.75% | 15.02% |
FCF Margin | - | -9.54% | -5.48% | -27.36% | -13.36% | -0.83% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 2.750 | 2.500 | 2.750 | 2.500 |
Dividend Per Share Growth | -27.27% | -27.27% | 10.00% | -9.09% | 10.00% | - |
Dividend Yield | 0.35% | 0.38% | 0.35% | 0.41% | 0.60% | 0.52% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 18.69 | 16.64 | 32.78 | 34.92 | 23.26 | 22.44 |
PS Ratio | 2.17 | 2.11 | 3.55 | 3.20 | 2.97 | 3.37 |